InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Diekman John d, Director. Officer active across 1 company, notably Zai Lab Ltd. In total, 9 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €377k. History available since 5 May 2021. The latest transaction was filed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Diekman John d
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
22,371 股American Depositary SharesSEC:0000905148-26-003028:0
10,831 股0American Depositary SharesSEC:0000905148-25-002216:0
21,253 股0American Depositary SharesSEC:0000905148-24-001747:0
18,903 股@ US$26.4542.3% 占其流量American Depositary SharesSEC:0000950170-23-031111:0
1,000 股@ US$50.170.0019% mcap7.0% 占其流量Ordinary SharesSEC:0001567619-22-002713:0
7,763 股0Ordinary SharesSEC:0001567619-22-000393:0
1,000 股@ US$91.659.5% 占其流量Ordinary SharesSEC:0001567619-21-019472:0
1,000 股@ US$149.5015.1% 占其流量Ordinary SharesSEC:0001567619-21-014550:0
1,000 股@ US$153.6215.3% 占其流量Ordinary SharesSEC:0001567619-21-009234:0
9 条申报中的 9 条
About Diekman John d
John D. Diekman is a Board Member at Zai Lab Ltd, a biopharmaceutical company. As a board member, John contributes to the company's governance and the development of strategies aimed at enhancing its performance. His experience in the biopharmaceutical sector is an asset to the board.
